
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1192 | 980 | 1192 | 1288 | 1519 | 2128 |
Fund Return | 19.16% | -1.98% | 19.16% | 8.81% | 8.73% | 7.85% |
Place in category | 147 | 150 | 147 | 75 | 81 | 54 |
% in Category | 67 | 67 | 67 | 51 | 47 | 37 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Satrix World Equity Tracker Fund A | 545.38M | 3.49 | 8.84 | 9.90 | ||
Satrix World Equity Tracker Fund E | 545.38M | 2.80 | 10.07 | 9.77 | ||
Satrix World Equity Tracker Fund C | 545.38M | 17.30 | 5.45 | 9.05 | ||
Satrix World Equity Tracker Fund IU | 545.38M | 17.96 | 6.03 | 9.62 | ||
Sanlam Global Financial D USD | 93.49M | 8.11 | 14.50 | 8.27 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Global Insurance Fund I Dist | 2.52B | 3.16 | 17.64 | 13.60 | ||
Global Insurance Fund R Acc | 2.52B | 3.07 | 17.08 | 13.08 | ||
Global Insurance Fund R Dist | 2.52B | 3.07 | 17.08 | 13.09 | ||
IE00B4Y53217 | 2.52B | 3.16 | 17.61 | 13.61 | ||
Sanlam Global Financial D USD | 93.49M | 8.11 | 14.50 | 8.27 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
U.S. Bancorp | US9029733048 | 5.23 | 42.68 | +0.95% | |
JPMorgan | US46625H1005 | 4.46 | 239.11 | +1.76% | |
Lancashire Holdings | BMG5361W1047 | 4.27 | 559.00 | -1.24% | |
Renaissancere | BMG7496G1033 | 4.06 | 240.41 | -0.08% | |
HSBC | GB0005405286 | 3.90 | 877.00 | -2.11% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review